This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Celiac Sprue Research Foundation, Oslo Universitetssykehus Hf, Universitetet I Oslo. Active years: 2009-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2 
1 out of 38 
1 out of 34 
Years Active: 2009-2020
Title: Ludvig Sollid: Innovator in Autoimmune Disease Research
Introduction
Ludvig Sollid is a prominent inventor based in Bekkestua, Norway. He has made significant contributions to the field of autoimmune diseases, particularly in the diagnosis and treatment of conditions like celiac disease. With a total of 2 patents, his work has garnered attention for its innovative approaches to understanding and managing these complex diseases.
Latest Patents
Sollid's latest patents include groundbreaking inventions that focus on the detection of gluten-specific T-cells. The first patent relates to compositions and methods for visualizing disease-specific T-cells. This invention is particularly relevant for diagnosing and monitoring autoimmune diseases characterized by the selective expansion of disease-specific effector memory T-cells. The second patent addresses the prolyl endopeptidase-mediated destruction of T cell epitopes in whole gluten. This invention aims to treat celiac sprue and dermatitis herpetiformis by interfering with HLA binding of immunogenic gluten peptides. The use of HLA-binding peptide inhibitors is a novel approach that decreases the antigenicity of gluten oligopeptides, thereby mitigating the immune response.
Career Highlights
Throughout his career, Sollid has worked with notable organizations such as the Celiac Sprue Research Foundation and the University of Oslo. His research has significantly advanced the understanding of gluten-related disorders and has opened new avenues for therapeutic interventions.
Collaborations
Sollid has collaborated with esteemed colleagues, including Thomas Marti and Øyvind Molberg. These partnerships have enriched his research and contributed to the development of innovative solutions in the field of autoimmune diseases.
Conclusion
Ludvig Sollid's contributions to autoimmune disease research through his patents and collaborations highlight his role as a leading inventor in this critical area of health. His work continues to influence the diagnosis and treatment of gluten-related disorders, making a lasting impact on patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile